Systems Provide the Right Diagnosis on All Patients with Industry-Leading Depth and Detail TUSTIN, Calif., June 16, 2014 – Cincinnati Children’s Hospital Medical Center has advanced its pediatric imaging capabilities by adding 10 AplioTM 500 ultrasound systems from Toshiba America Medical Systems, Inc. The facility is utilizing the Aplio 500 ultrasounds to perform high quality […]
Lung-MAP Trial Will Test Five Investigational Approaches, Including Amgen’s Rilotumumab, an Investigational Fully Human Monoclonal Antibody THOUSAND OAKS, Calif., June 16, 2014 /PRNewswire/ — Amgen (NASDAQ:AMGN) announced today that it will collaborate with the National Cancer Institute (NCI), part of the National Institutes of Health, and other public and private sector partners on the Lung […]
WHITEHOUSE STATION, June 14, 2014 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc analysis showing that patients with type 2 diabetes having treatment intensified with insulin glargine therapy while also being treated with JANUVIA® (sitagliptin) 100 mg once-daily had a lower incidence of nighttime (nocturnal) […]
Real-world study presented at the American Diabetes Association 74th Scientific Sessions WHITEHOUSE STATION, June 14, 2014 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a late-breaking observational study that assessed the differences in time to initiation of insulin use and the proportion of the population initiating insulin among […]
New Research Initiative Seeks to Identify Unmet Needs and Address Key Gaps in the Management of Type 2 Diabetes WHITEHOUSE STATION, N.J., June 13, 2014 –(BUSINESS WIRE)– Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the launch of a global registry to evaluate the experiences and outcomes of approximately 20,000 […]
Phase 3 Program Underway to Further Assess Brodalumab as Potential Treatment for People Living With Psoriatic Arthritis THOUSAND OAKS, Calif. and LONDON, June 11, 2014 /PRNewswire/ — Amgen (NASDAQ:AMGN) and AstraZeneca today announced that results from a Phase 2 study evaluating brodalumab in 168 patients with psoriatic arthritis were published in The New England Journal […]
PITTSBURGH, June 11, 2014 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) today announced that it has launched Risedronate Sodium Tablets USP, 150 mg, the generic version of Warner Chilcott’s Actonel® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated […]
Celesteion Delivers a More Comfortable Patient Experience with the Industry’s Largest Bore, Widest Field-of-View and Fastest Imaging TUSTIN, Calif., June 9, 2014 – Oncology departments can now provide their patients with a better PET/CT imaging experience using Toshiba America Medical Systems, Inc.’s all-new Celesteion (pending 510(k) clearance). The versatile system combines high performance PET and […]
PITTSBURGH, June 9, 2014 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) today announced that it has launched Carboplatin Injection, 50 mg/5 ml, in multi-dose vials, which is the generic version of Bristol-Myers Squibb’s Paraplatin® Injection. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this […]
THOUSAND OAKS, Calif., June 9, 2014 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the appointment of David W. Meline as executive vice president and chief financial officer (CFO), effective July 21, 2014. He will be responsible for Amgen’s finance and investor relations operations, reporting to Robert A. Bradway, chairman and chief executive officer. Meline will succeed […]